EUVIMEDEUVIMED entdecken
MetaanalyseOpen Access · CC BY-NC 4.0

Circulating Proteins for Prediction of Kidney Disease Progression and Cardiovascular Outcomes: Individual Participant Data Meta-Analysis of Four Cohorts

Carolina Lopez-Silva, Aditya Surapaneni, Josef Coresh, Teresa K Chen, Pascal Schlosser, Eugene P Rhee, Sushrut S Waikar, Insa M Schmidt, Rajat Deo, Peter Ganz, Ruth Dubin, Vasan S Ramachandran und 9 weitere

American Journal of Nephrology · 2025

DOI: 10.1159/000547138 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift American Journal of Nephrology, 2025. Verfasst von Carolina Lopez-Silva und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Receptors, Tumor Necrosis Factor, Type I, Hepatitis A Virus Cellular Receptor 1, Receptors, Tumor Necrosis Factor, Type II. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

KIM-1, TNFRSF1A, and TNFRSF1B have been accepted as early risk markers in diabetic kidney disease by the US Food and Drug Administration. Whether they may be useful in identifying high-risk patients for cardiovascular/kidney clinical trial enrollment in other important subgroups is uncertain.

Methods

We evaluated the potential prognostic enrichment of KIM-1, TNFRSF1A, and TNFRSF1B in four cohorts: the Atherosclerosis Risk in Communities (ARIC) (N = 4,594, mean age 76 years, 55% women, mean eGFR 68 mL/min/1.73 m2), African American Study of Kidney Disease and Hypertension (AASK) (N = 705, mean age 55 years, 39% women, mean mGFR 46 mL/min/1.73 m2), Chronic Renal Insufficiency Cohort (CRIC) (N = 2,943, mean age 59 years, 45% women, mean eGFR 35 mL/min/1.73 m2), and Boston Kidney Biopsy Cohort (BKBC) (N = 434, mean age 54 years, 48% women, mean eGFR 51 mL/min/1.73 m2). We evaluated three outcomes: 40% glomerular filtration rate (GFR) decline, kidney failure, and incident cardiovascular disease (CVD) overall and in two subgroups historically underrepresented in clinical trials: participants with no diabetes, and those with albuminuria

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesReceptors, Tumor Necrosis Factor, Type IHepatitis A Virus Cellular Receptor 1Receptors, Tumor Necrosis Factor, Type IIRenal Insufficiency, ChronicHumansDisease ProgressionFemaleBiomarkersMiddle AgedMaleAgedPrognosisGlomerular Filtration RateCohort StudiesRisk FactorsAlbuminuria

Stichwörter der Autor:innen

KIM-1OutcomesTNFRSF1ATNFRSF1B

Substanzen

Receptors, Tumor Necrosis Factor, Type IBiomarkersHAVCR1 protein, humanHepatitis A Virus Cellular Receptor 1Receptors, Tumor Necrosis Factor, Type IITNFRSF1A protein, humanTNFRSF1B protein, human

Autor:innen und Institutionen

  • Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Division of Precision Medicine, NYU Grossman School of Medicine, New York, New York, USA.
  • Optimal Aging Institute, NYU Grossman School of Medicine, New York, New York, USA.
  • Kidney Health Research Collaborative and Division of Nephrology, Department of Medicine, University of California San Francisco, and San Francisco VA Health Care System, San Francisco, California, USA.
  • Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
  • Institute of Genetic Epidemiology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.

Förderung

  • NIDDK NIH HHS
  • NCATS NIH HHS
  • NHLBI NIH HHS
  • NCRR NIH HHS
  • NIGMS NIH HHS

Zitieren

APA

Lopez-Silva, C., Surapaneni, A., Coresh, J., Chen, T. K., Schlosser, P., Rhee, E. P., Waikar, S. S., Schmidt, I. M., Deo, R., Ganz, P., Dubin, R., Ramachandran, V. S., Kimmel, P. L., Schrauben, S. J., Parikh, C. R., Bonventre, J. V., Dobre, M., Rao, P. S., Ricardo, A. C., …, & Grams, M. E. (2025). Circulating Proteins for Prediction of Kidney Disease Progression and Cardiovascular Outcomes: Individual Participant Data Meta-Analysis of Four Cohorts. American Journal of Nephrology. https://doi.org/10.1159/000547138

Vancouver

Lopez-Silva C, Surapaneni A, Coresh J, Chen TK, Schlosser P, Rhee EP, et al. Circulating Proteins for Prediction of Kidney Disease Progression and Cardiovascular Outcomes: Individual Participant Data Meta-Analysis of Four Cohorts. American Journal of Nephrology. 2025. doi:10.1159/000547138

BibTeX
@article{LopezSilva2025,
  author = {Lopez-Silva, Carolina and Surapaneni, Aditya and Coresh, Josef and Chen, Teresa K and Schlosser, Pascal and Rhee, Eugene P and Waikar, Sushrut S and Schmidt, Insa M and Deo, Rajat and Ganz, Peter and Dubin, Ruth and Ramachandran, Vasan S and Kimmel, Paul L and Schrauben, Sarah J and Parikh, Chirag R and Bonventre, Joseph V and Dobre, Mirela and Rao, Panduranga S and Ricardo, Ana C and Weir, Matthew R and Grams, Morgan E},
  title = {Circulating Proteins for Prediction of Kidney Disease Progression and Cardiovascular Outcomes: Individual Participant Data Meta-Analysis of Four Cohorts},
  journal = {American Journal of Nephrology},
  year = {2025},
  doi = {10.1159/000547138}
}
Kostenlos starten →